Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Atara Biotherapeutics, Inc. (NASDAQ: ATRA)
ATRA Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
253.30%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-40.30%
ATRA Stock Analysis
ATRA
PE Ratio:
ATRA
PEG Ratio:
Not Available
ATRA
Forward EPS Growth (12 month):
0.00%
ATRA
PS Ratio:
3.7
ATRA
PSG Ratio:
ATRA
Forward Revenue Growth (12 month):
260.40%
ATRA Articles
No data was found